Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f62c742b87bf1c93c55fed3f7db7ef4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_154765e9e47f4cfd16ebc1b97ac58d7f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K23-00 |
filingDate |
2011-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9de8aa444bf552daed537fb628341ae |
publicationDate |
2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8697123-B2 |
titleOfInvention |
Medication on the basis of 3,3′-diindolylmethane (DIM) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases |
abstract |
The invention relates to medicine and chemico-pharmaceutical industry. A medication for treating human hyperplastic and inflammatory diseases containing 3,3′-diindolylmethane as an active agent and a carrier containing a mixture of cod-liver oil and at least one polysorbate at the following proportions of the components in mass %: n n n n n n n n n n n n 3,3′-diindolylmethane n 1-20 n n n cod-liver oil n 10-20 n n n polysorbate n the balance. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016164770-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799479-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441569-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337961-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020179337-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018280347-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9918965-B2 |
priorityDate |
2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |